pembrolizumab
merck
['gyn', 'pembro']
updated data support the use of pembrolizumab in combination with chemotherapy as first-line standard care for patients with persistent, recurrent, or metastatic cervical cancer. #asco23 #gyncsm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.